As the Affordable Care Act passed its 15th anniversary this year, Supreme Court Justices continue to deliberate the fate of ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

Adding venetoclax to decitabine-cedazuridine significantly enhanced response rates in patients with higher-risk ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

NYOH joins OneOncology to leverage its patient-first culture and advanced technology solutions, enhancing cancer care delivery and practice growth. The partnership supports NYOH's expansion, including ...

John Michael O'Brien, PharmD, MPH, discussed the changes in managed care over the past 30 years to commemorate the 30th ...

Following the Trump Administration’s mandate to cut $2.6 billion in NIH contracts, the Women’s Health Initiative shares HHS ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

A new analysis links higher triglyceride-glucose (TyG) and TyG–body mass index (TyG-BMI) levels to increased colorectal ...

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...